查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1956270

日本運動醫學市場規模、佔有率、趨勢和預測：按產品、應用、最終用戶和地區分類，2026-2034年

Japan Sports Medicine Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

預計到 2025 年，日本運動醫學市場規模將達到 4.2278 億美元，到 2034 年將達到 6.63 億美元，2026 年至 2034 年的複合年成長率為 5.13%。

由於人口老化但活躍度不斷提高，以及休閒和競技運動參與度的增加，日本的運動醫學市場正經歷強勁成長。先進的醫療基礎設施、微創手術技術的進步以及再生醫學療法的日益普及，都提升了治療效果。日本體育廳對體育鍛鍊的推廣，以及為籌備重大國際體育賽事所做的準備，都促進了日本運動醫學市場佔有率的擴大。

要點和見解：

  • 按產品分類：到 2025 年，身體重組領域將以 40.23% 的市場佔有率領先，這主要得益於對關節鏡手術器械、骨折修復產品、骨生物製藥和先進植入技術的需求不斷成長，這些技術能夠有效進行運動相關肌肉骨骼損傷的外科重組。
  • 按應用領域分類：到 2025 年，膝關節損傷將以 18.74% 的市場佔有率領先，這反映出運動員和活躍人群中需要專門的整形外科干預的疾病（如前交叉韌帶斷裂、半月軟骨和退化性關節疾病）的患病率很高。
  • 按最終用戶分類：到 2025 年，醫院將佔據最大的市場佔有率，達到 52.35%，這得益於領先的醫療機構提供的綜合診斷能力、先進的外科手術設施、多學科運動醫學團隊和綜合復健服務。
  • 按地區分類：到 2025 年，關東地區將佔據最大的市場佔有率，達到 34%。這是因為東京都市圈集中了專業的運動醫學設施、大學醫院、職業運動隊伍和先進的醫療基礎設施。
  • 主要企業：日本運動醫學市場的領先製造商正在拓展產品系列，推廣再生醫學技術，並加強與醫療機構的合作。對關節鏡器械、生物導引植入和數位健康解決方案的投資正在加速創新，並有助於改善治療效果。

隨著醫療機構、體育組織和消費者積極採用創新療法來治療運動傷害和肌肉骨骼疾病，日本的運動醫學市場蓬勃發展。完善的醫療基礎設施和對技術創新的高度重視，推動了微創手術和再生醫學的廣泛應用。各年齡層健康意識的提升，促進了健身活動的參與，從而增加了對損傷預防和復健產品的需求。日本政府透過日本體育廳持續致力於推廣體育運動，體現了其對全國運動員醫療保健和體能提升措施的持續投入。政府的支持，加上老齡化社會積極生活方式的趨勢以及外科和復健設備的不斷進步，預計將推動市場持續擴張。日本正積極籌備即將到來的國際體育賽事，並滿足日益成長的各年齡層活躍人群不斷變化的醫療需求。

日本運動醫學市場的發展趨勢：

再生醫學的引入正在改變治療通訊協定。

再生醫學療法的引入正在重塑日本的運動傷害治療方法。富血小板血漿（PRP）注射、幹細胞療法和生物引導植入因其促進組織癒合和縮短恢復時間的有效性而已被廣泛認可。醫療機構越來越認知到這些生物療法在治療運動相關肌肉骨骼損傷（從韌帶斷裂到軟骨損傷）方面的潛力。這種向再生醫學的轉變反映了一種臨床趨勢，即注重恢復組織自然功能，而非僅僅依賴傳統的手術干預，並正在推動日本運動醫學市場的成長。

數位健康整合實現了遠端患者監護

穿戴式科技和數位健康平台正在革新運動醫學專業人士監測患者復健和運動表現的方式。先進的感測器能夠持續追蹤生理參數、運動模式和復健進展。這些技術在醫療和健身領域的日益普及，反映了日本消費者和醫療服務提供者對連線健診解決方案日益成長的需求。這些創新有助於制定個人化治療通訊協定、及早發現潛在損傷，並透過整合的遠距遠端醫療平台實現運動員與醫療服務提供者之間的無縫溝通。

透過微創手術技術改善患者預後

在日本，先進的關節鏡和微創手術技術正逐漸成為運動醫學機構的標準治療方法。與傳統開放性手術相比，這些技術能夠減少組織損傷，縮短住院時間和復原期。先進的可視化系統、導航技術和專用器械使外科醫生能夠更精準地完成複雜的重組手術。對生物導引植入及類似技術的需求日益成長，顯示人們越來越需要既能促進自然癒合過程又能最大限度地減少手術創傷的解決方案。

2026-2034年市場展望：

受人口結構變化、技術創新和醫療服務模式演變的推動，日本運動醫學市場預計將在預測期內持續擴張。各年齡層運動參與率的提高，以及人們對運動傷害預防意識的增強，將持續推動對專業醫療產品和服務的需求。預計該市場2025年的營收將達到4.2278億美元，到2034年將達到6.63億美元，2026年至2034年的複合年成長率（CAGR）為5.13%。對先進外科技術、再生醫學和數位健康整合的策略性投資將增強市場競爭力並改善病患治療效果。

本報告解答的關鍵問題

1. 日本運動醫學市場的規模有多大？

2. 日本運動醫學市場的預期成長率是多少？

3. 在日本運動醫學市場中，哪一種產品佔最大的市佔率？

4. 市場成長的主要促進因素是什麼？

5. 日本運動醫學市場面臨的主要挑戰是什麼？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本運動醫學市場：簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章：日本運動醫學市場：現狀

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本運動醫學市場：依產品類別分類

  • 身體重組
  • 身體支持和恢復
  • 物理監測與評估
  • 壓力衣
  • 配件

第7章：日本運動醫學市場：依應用領域細分

  • 膝傷
  • 肩部受傷
  • 足部和踝部損傷
  • 髖部和鼠蹊部損傷
  • 肘部和腕部損傷
  • 背部和脊椎損傷
  • 其他

第8章：日本運動醫學市場－依最終用戶細分

  • 醫院
  • 整形外科診所
  • 健身訓練中心
  • 門診手術中心（ASC）
  • 其他

第9章：日本運動醫學市場：依地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部/中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第10章：日本運動醫學市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第11章：主要企業概況

第12章：日本運動醫學市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第13章附錄

簡介目錄
Product Code: SR112026A43897

The Japan sports medicine market size was valued at USD 422.78 Million in 2025 and is projected to reach USD 663.00 Million by 2034 , growing at a compound annual growth rate of 5.13% from 2026-2034 .

The Japan sports medicine market is experiencing robust expansion driven by the convergence of an aging yet increasingly active population and rising participation in recreational and competitive sports activities. Advanced healthcare infrastructure, technological innovations in minimally invasive surgical techniques, and growing adoption of regenerative medicine therapies are strengthening treatment outcomes. Government initiatives through the Japan Sports Agency promoting physical fitness, combined with preparations for major international sporting events, are enhancing the Japan sports medicine market share.

KEY TAKEAWAYS AND INSIGHTS:

  • By Product: Body reconstruction dominates the market with a share of 40.23% in 2025 , driven by rising demand for arthroscopic devices, fracture repair products, orthobiologics, and advanced implant technologies that enable effective surgical reconstruction of sports-related musculoskeletal injuries.
  • By Application: Knee injuries lead the market with a share of 18.74% in 2025 , reflecting the high prevalence of anterior cruciate ligament tears, meniscal damage, and degenerative joint conditions requiring specialized orthopedic interventions among athletes and active individuals.
  • By End User: Hospitals hold the largest share at 52.35% in 2025 , owing to comprehensive diagnostic capabilities, advanced surgical facilities, multidisciplinary sports medicine teams, and integrated rehabilitation services offered by major medical institutions.
  • By Region: Kanto Region represents the largest segment with 34% share in 2025 , supported by the concentration of specialized sports medicine facilities, university hospitals, professional sports teams, and advanced healthcare infrastructure in the Greater Tokyo metropolitan area.
  • Key Players: Leading manufacturers in the Japan sports medicine market are expanding product portfolios, advancing regenerative medicine technologies, and strengthening partnerships with healthcare institutions. Their investments in arthroscopic devices, bioinductive implants, and digital health solutions are accelerating innovation and improving treatment outcomes.

The Japan sports medicine market is advancing as healthcare providers, sports organizations, and consumers embrace innovative treatment solutions for athletic injuries and musculoskeletal conditions. The country's well-established healthcare infrastructure and emphasis on technological innovation are enabling widespread adoption of minimally invasive procedures and regenerative therapies. Growing health consciousness across generations is driving participation in fitness activities, subsequently increasing demand for injury prevention and rehabilitation products. Sustained governmental commitment to sports promotion through the Japan Sports Agency demonstrates continued investment in athlete healthcare and physical fitness initiatives nationwide. This governmental support, combined with demographic trends favoring active lifestyles among aging populations and continuous technological advancements in surgical devices and rehabilitation equipment, positions the market for continued expansion as the nation prepares for upcoming international sporting events and addresses the evolving healthcare needs of its increasingly active population across all age groups.

JAPAN SPORTS MEDICINE MARKET TRENDS:

Regenerative Medicine Adoption Transforming Treatment Protocols

The integration of regenerative medicine therapies is reshaping sports injury treatment approaches across Japan. Platelet-rich plasma injections, stem cell-based treatments, and bioinductive implants are gaining acceptance for their ability to accelerate tissue healing and reduce recovery times. Healthcare providers increasingly recognize the potential of these biological solutions for addressing sports-related musculoskeletal injuries, from ligament tears to cartilage damage. This shift toward regenerative approaches reflects broader clinical emphasis on restoring natural tissue function rather than relying solely on traditional surgical interventions, supporting the Japan sports medicine market growth.

Digital Health Integration Enabling Remote Patient Monitoring

Wearable technology and digital health platforms are revolutionizing how sports medicine professionals monitor patient recovery and athletic performance. Advanced sensors enable continuous tracking of physiological parameters, movement patterns, and rehabilitation progress. The growing adoption of these technologies across healthcare and fitness applications reflects increasing demand for connected health solutions among Japanese consumers and providers. These innovations facilitate personalized treatment protocols, early detection of potential injuries, and seamless communication between athletes and healthcare providers through integrated telehealth platforms.

Minimally Invasive Surgical Techniques Improving Patient Outcomes

Advanced arthroscopic procedures and minimally invasive surgical techniques are becoming standard practice in Japanese sports medicine facilities. These approaches offer reduced tissue trauma, shorter hospital stays, and accelerated rehabilitation timelines compared to traditional open surgeries. Sophisticated visualization systems, navigation technologies, and specialized instrumentation enable surgeons to perform complex reconstructive procedures with enhanced precision. The growing preference for bioinductive implants and similar technologies demonstrates the expanding demand for solutions that support natural healing processes while minimizing surgical invasiveness.

MARKET OUTLOOK 2026-2034:

The Japan sports medicine market is poised for sustained expansion throughout the forecast period, driven by demographic shifts, technological innovations, and evolving healthcare delivery models. Increasing sports participation rates across age groups, combined with growing awareness of injury prevention, will continue generating demand for specialized medical products and services. The market generated a revenue of USD 422.78 Million in 2025 and is projected to reach a revenue of USD 663.00 Million by 2034, growing at a compound annual growth rate of 5.13% from 2026-2034. Strategic investments in advanced surgical technologies, regenerative therapies, and digital health integration will strengthen market competitiveness and improve patient outcomes.

JAPAN SPORTS MEDICINE MARKET REPORT SEGMENTATION:

Product Insights:

  • Body Reconstruction
  • Fracture and Ligament Repair Products
  • Arthroscopy Devices
  • Implants
  • Orthobiologics
  • Prosthetics
  • Body Support and Recovery
  • Braces and Supports
  • Physiotherapy
  • Thermal Therapy
  • Ultrasound Therapy
  • Laser Therapy
  • Electrostimulation Therapy
  • Body Monitoring and Evaluation
  • Cardiac Monitoring
  • Respiratory Monitoring
  • Hemodynamic Monitoring
  • Musculoskeletal Monitoring
  • Compression Clothing
  • Accessories
  • Bandages
  • Disinfectants
  • Tapes
  • Others
  • Body reconstruction dominates with a market share of 40.23% of the total Japan sports medicine market in 2025 .
  • The body reconstruction segment encompasses arthroscopy devices, fracture and ligament repair products, orthobiologics, implants, and prosthetics essential for surgical treatment of sports injuries. Rising demand for advanced reconstructive solutions reflects the growing complexity of athletic injuries and patient expectations for complete functional restoration. In October 2023, Smith+Nephew launched its REGENETEN Bioinductive Implant in Japan at the 50th Annual Meeting of the Japan Shoulder Society, providing healing options for patients with rotator cuff tears ranging from partial thickness to massive full-thickness tears exceeding 5 centimeters.
  • Technological innovations in bioinductive materials, bioabsorbable implants, and minimally invasive surgical instrumentation are enhancing treatment outcomes and reducing recovery periods. Surgeons increasingly prefer arthroscopic approaches that minimize tissue trauma while enabling precise reconstruction of damaged ligaments, tendons, and cartilage. The segment benefits from ongoing research collaborations between medical device manufacturers and academic institutions developing next-generation orthopedic solutions tailored to the anatomical and physiological characteristics of Japanese patients, ensuring optimal surgical outcomes across diverse injury presentations.

Application Insights:

  • Knee Injuries
  • Shoulder Injuries
  • Foot and Ankle Injuries
  • Hip and Groin Injuries
  • Elbow and Wrist Injuries
  • Back and Spine Injuries
  • Knee injuries lead with a share of 18.74% of the total Japan sports medicine market in 2025 .
  • Knee injuries represent the most prevalent application category driven by high incidence of anterior cruciate ligament tears, meniscal damage, and patellofemoral disorders among athletes and active individuals. The anatomical complexity of the knee joint and biomechanical stresses during athletic activities necessitates specialized diagnostic and treatment approaches. Sports medicine professionals across Japan consistently observe knee-related conditions as among the most common presentations requiring intervention across all athletic populations.
  • Treatment modalities for knee injuries encompass arthroscopic reconstruction procedures, ligament repair techniques, cartilage restoration therapies, and comprehensive rehabilitation programs. The segment benefits from continuous advancements in surgical instrumentation, imaging technologies, and regenerative medicine applications that improve diagnostic accuracy and treatment efficacy. Growing participation in high-impact sports such as soccer, basketball, and skiing contributes to sustained demand for knee injury management solutions across professional, amateur, and recreational athletic populations throughout Japan.

End User Insights:

  • Hospitals
  • Orthopedic Specialty Clinics
  • Fitness and Training Centers
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals exhibit a clear dominance with a 52.35% share of the total Japan sports medicine market in 2025 .
  • Hospitals serve as primary treatment centers for sports injuries requiring comprehensive diagnostic evaluation, surgical intervention, and post-operative rehabilitation. Major university hospitals and medical centers operate dedicated sports medicine departments staffed by orthopedic surgeons, sports medicine physicians, physical therapists, and athletic trainers. These institutions offer integrated services spanning injury assessment, advanced imaging, surgical treatment, and structured rehabilitation programs designed to restore athletes to competitive activity levels safely and efficiently.
  • The hospital segment benefits from substantial capital investments in advanced surgical technologies, including arthroscopic equipment, robotic-assisted surgery systems, and sophisticated imaging modalities. Leading institutions maintain partnerships with professional sports teams and national athletic organizations, providing specialized care for elite competitors while conducting clinical research advancing treatment protocols. Hospital-based sports medicine programs increasingly emphasize multidisciplinary approaches integrating orthopedic expertise with nutritional counseling, psychological support, and performance optimization services.

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region represents the leading segment with a 34% share of the total Japan sports medicine market in 2025 .
  • The Kanto Region dominates the Japan sports medicine market owing to the concentration of advanced healthcare infrastructure, specialized orthopedic facilities, and professional sports organizations in the Greater Tokyo metropolitan area. The region hosts numerous university hospitals, research institutions, and private specialty clinics offering comprehensive sports medicine services. In January 2025, Tokyo Sports and Orthopaedic Clinic established its Kitasando branch in Shibuya, featuring a five-story facility with MRI imaging, and 19 inpatient beds.
  • The region benefits from substantial population density, higher disposable incomes enabling access to premium healthcare services, and proximity to major sporting venues and athletic training facilities. Professional baseball, soccer, and Olympic sport organizations headquartered in the Kanto Region generate consistent demand for specialized injury treatment and prevention programs. The concentration of elite athletes and recreational sports enthusiasts creates a robust patient base seeking quality care. Additionally, the presence of leading medical device distributors and pharmaceutical companies facilitates rapid adoption of innovative sports medicine technologies throughout the regional healthcare network.

MARKET DYNAMICS:

Growth Drivers:

  • Why is the Japan Sports Medicine Market Growing?
  • Aging Yet Increasingly Active Population Driving Healthcare Demand
  • Japan's demographic profile significantly influences sports medicine demand as the nation maintains the world's highest proportion of elderly citizens while simultaneously experiencing rising fitness consciousness across age groups. In September 2024, people aged 65 and older comprised a record 29.3% of the country's population, while those 75 and above accounted for 16.8%. Despite advanced age, Japanese seniors demonstrate remarkable engagement in physical activities. A 2024 survey of 3,000 adults found that 54.8% played sports at least once a week, representing a substantial increase from 23.7% in 1992. This combination of longevity and active lifestyle generates sustained demand for sports medicine products addressing age-related musculoskeletal conditions alongside athletic injuries.
  • Government Investment Supporting Sports Infrastructure Development
  • Substantial governmental commitment to sports promotion and athlete healthcare strengthens the foundation for market expansion. The Ministry of Education, Culture, Sports, Science, and Technology and the Japan Sports Agency allocate significant budgetary resources toward national sports development initiatives, with dedicated funding streams designated for improving international competitiveness among Japanese athletes. National sports promotion plans outline comprehensive measures including healthcare provisions for athletes at all competitive levels. Ongoing preparations for major international sporting events hosted within Japan are driving infrastructure investments that benefit sports medicine service delivery nationwide. These governmental initiatives create favorable conditions for healthcare providers, equipment manufacturers, and rehabilitation specialists operating within the sports medicine sector.
  • Technological Advancements Enabling Superior Treatment Outcomes
  • Continuous innovations in medical devices, digital health platforms, and regenerative medicine therapies are transforming sports injury treatment capabilities. In April 2024, OMRON Healthcare acquired Luscii Healthtech, a digital health and remote consultation service platform provider, demonstrating the integration of advanced telehealth solutions into sports medicine practice. Wearable technology in Japan facilitates continuous patient monitoring and personalized rehabilitation protocols. Advances in arthroscopic instrumentation, bioinductive implants, and AI-powered diagnostic tools enable surgeons to achieve superior outcomes while minimizing recovery periods, driving adoption of premium sports medicine solutions across healthcare facilities.

Market Restraints:

  • What Challenges the Japan Sports Medicine Market is Facing?
  • High Treatment Costs Limiting Access
  • Premium pricing for advanced sports medicine technologies including imported orthopedic implants, robotic surgical systems, and regenerative therapies creates accessibility barriers for some patient populations. Insurance coverage limitations for innovative treatments such as stem cell therapies and platelet-rich plasma injections often require substantial out-of-pocket expenditures, potentially restricting market penetration.
  • Regulatory Complexity Affecting Product Introduction
  • Japan's stringent medical device regulatory framework, including requirements under the Act on Safety of Regenerative Medicine, necessitates comprehensive approval processes for innovative sports medicine products. Manufacturers must navigate extensive documentation, clinical validation, and certification requirements that extend timelines for introducing advanced treatment technologies to the market.
  • Geographic Disparities in Healthcare Access
  • Advanced sports medicine capabilities remain concentrated in major urban centers, creating access disparities for patients in rural and remote regions. Limited availability of specialized orthopedic facilities, certified sports medicine physicians, and comprehensive rehabilitation services outside metropolitan areas constrains market growth potential in underserved geographic segments.

COMPETITIVE LANDSCAPE:

  • The Japan sports medicine market exhibits a competitive landscape characterized by the presence of established multinational medical technology companies alongside domestic healthcare providers. Leading manufacturers focus on expanding product portfolios, advancing regenerative medicine technologies, and developing minimally invasive surgical solutions. Competition intensifies around arthroscopic devices, orthobiologic products, and digital health platforms. Strategic partnerships between medical device companies and academic institutions drive research innovation, while collaborations with professional sports organizations enhance market visibility and clinical validation of new technologies.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the Japan sports medicine market?

2. What is the projected growth rate of the Japan sports medicine market?

3. Which product held the largest Japan sports medicine market share?

4. What are the key factors driving market growth?

5. What are the major challenges facing the Japan sports medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Sports Medicine Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Sports Medicine Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Sports Medicine Market - Breakup by Product

  • 6.1 Body Reconstruction
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Fracture and Ligament Repair Products
      • 6.1.3.2 Arthroscopy Devices
      • 6.1.3.3 Implants
      • 6.1.3.4 Orthobiologics
      • 6.1.3.5 Prosthetics
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Body Support and Recovery
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Braces and Supports
      • 6.2.3.2 Physiotherapy
        • 6.2.3.2.1 Thermal Therapy
        • 6.2.3.2.2 Ultrasound Therapy
        • 6.2.3.2.3 Laser Therapy
        • 6.2.3.2.4 Electrostimulation Therapy
    • 6.2.4 Market Forecast (2026-2034)
  • 6.3 Body Monitoring and Evaluation
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Cardiac Monitoring
      • 6.3.3.2 Respiratory Monitoring
      • 6.3.3.3 Hemodynamic Monitoring
      • 6.3.3.4 Musculoskeletal Monitoring
    • 6.3.4 Market Forecast (2026-2034)
  • 6.4 Compression Clothing
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Accessories
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Segmentation
      • 6.5.3.1 Bandages
      • 6.5.3.2 Disinfectants
      • 6.5.3.3 Tapes
      • 6.5.3.4 Others
    • 6.5.4 Market Forecast (2026-2034)

7 Japan Sports Medicine Market - Breakup by Application

  • 7.1 Knee Injuries
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Shoulder Injuries
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Foot and Ankle Injuries
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Hip and Groin Injuries
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Elbow and Wrist Injuries
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Back and Spine Injuries
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2020-2025)
    • 7.7.2 Market Forecast (2026-2034)

8 Japan Sports Medicine Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Orthopedic Specialty Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Fitness and Training Centers
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Ambulatory Surgical Centers (ASCs)
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2020-2025)
    • 8.5.2 Market Forecast (2026-2034)

9 Japan Sports Medicine Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Sports Medicine Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Products Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Products Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Products Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Products Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Products Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Sports Medicine Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix